Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.

Industry: Pharmaceutical Preparations Peers: Aridis Pharmaceuticals, Inc. BIOCEPT INC Soleno Therapeutics Inc Gyre Therapeutics Inc Cyclo Therapeutics, Inc. MetaVia Inc Transcode Therapeutics Inc